BNTC
Benitec Biopharma Ltd
9.00$
-6.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -9,518.6% | -2,493.0% | -357.5% | -470.7% | -1,074.0% | -919.7% | -1,542.6% | -2,027.7% | -976.1% | -600.7% | -945.8% | -1,537.2% | -7,816.8% | -4,239.3% | -222.6% | 27.5% | -7,768.0% | -21,749.2% | -21,779.5% | -24,016.0% | -8,982.9% | – | – | |
| 913.1% | 263.2% | – | 0.5% | 1.7% | 2.3% | 2.4% | 5.8% | 4.0% | – | 1.4% | 11.8% | 4.4% | 110.8% | 3.2% | 0.9% | 385.6% | 718.6% | 537.0% | 508.0% | 158.8% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 197.1% | – | 5.5% | 244.3% | 1,074.6% | 1,191.8% | 602.7% | 384.3% | – | – | |
| – | – | – | – | – | – | – | – | – | – | 38.1% | 52.4% | 1,087.7% | 327.7% | 8.0% | 4.0% | 246.4% | 1,047.5% | 1,205.5% | 606.7% | – | – | – | |
| -420.7% | 31.9% | -55.8% | 190.1% | -212.2% | 66.6% | 24.7% | 306.8% | -232.4% | 10.5% | -266.1% | 136.2% | 135.8% | 388.0% | 33.8% | 7.6% | 129.9% | 13.6% | 1,420.5% | 952.0% | 543.5% | – | – | |
| 60.9% | 153.4% | 0.5% | 2.2% | 3.8% | 0.1% | 1.7% | 17.8% | 5.5% | 5.8% | 49.7% | 61.4% | 98.8% | 67.1% | 1.4% | 2.3% | 97.9% | 374.6% | 17.8% | 1.3% | 82.9% | – | – | |
| -353.3% | -145.8% | -0.5% | -2.2% | -3.8% | -0.1% | -1.7% | -17.8% | -5.5% | 29.4% | -3.3% | -61.4% | -132.3% | -154.2% | -3.3% | -2.3% | -96.9% | -374.6% | -17.8% | -1.3% | -82.9% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | 286.6% | – | – | |
| -712.0% | – | – | – | – | – | – | – | – | – | 4,086.8% | 61.1% | 7,528.2% | 4,120.8% | 200.4% | 0.0% | 1,824.7% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| 14,741.5% | 2,904.3% | 133.2% | 1,486.5% | 4.9% | 915.7% | 743.0% | 5,886.1% | -124.8% | 238.9% | 3,986.8% | 9.0% | 6,773.2% | 4,053.0% | 193.3% | -3.9% | 1,824.7% | 38,172.9% | 21,938.4% | 21,353.3% | 31,494.9% | – | – | |
| – | – | 38.7% | 1,120.5% | -1,559.5% | -13.2% | -23.1% | 4,519.9% | -1,189.9% | -364.3% | 3,128.2% | -1,164.4% | -1,375.9% | -436.5% | -29.3% | 25.4% | -6,100.0% | 16,894.9% | -21,517.8% | -2,114.7% | 22,425.5% | – | – | |
| -9,579.5% | -2,646.4% | -358.0% | -473.0% | -1,077.8% | -919.8% | -1,544.2% | -2,045.5% | -981.6% | -1,843.6% | -1,063.4% | -1,598.6% | -7,915.6% | -4,306.4% | -195.7% | 25.1% | -7,866.0% | -22,123.7% | -21,797.3% | -24,017.3% | -9,065.7% | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.